Advanced search
Publication Cover
Epigenetics Volume 8, 2013 - Issue 5
Submit an article Journal homepage
1,720
Views
43
CrossRef citations to date
0
Altmetric
Brief Report

Aberrant promoter hypermethylation of PBRM1, BAP1, SETD2, KDM6A and other chromatin-modifying genes is absent or rare in clear cell RCC

Ilsiya Ibragimova Cancer Epigenetics Program and Kidney Keystone Program; Fox Chase Cancer Center; Philadelphia, PA USA
,
Marie E. Maradeo Cancer Epigenetics Program and Kidney Keystone Program; Fox Chase Cancer Center; Philadelphia, PA USA
,
Essel Dulaimi Department of Pathology and Kidney Keystone Program; Fox Chase Cancer Center; Philadelphia, PA USA
&
Paul Cairns Cancer Epigenetics Program and Kidney Keystone Program; Fox Chase Cancer Center; Philadelphia, PA USACorrespondence[email protected]
Pages 486-493 | Received 18 Mar 2013, Accepted 04 Apr 2013, Published online: 01 May 2013

Citations (43)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Francesco Piva, Matteo Santoni, Marc R Matrana, Suma Satti, Matteo Giulietti, Giulia Occhipinti, Francesco Massari, Liang Cheng, Antonio Lopez-Beltran, Marina Scarpelli, Giovanni Principato, Stefano Cascinu & Rodolfo Montironi. (2015) BAP1, PBRM1 and SETD2 in clear-cell renal cell carcinoma: molecular diagnostics and possible targets for personalized therapies. Expert Review of Molecular Diagnostics 15:9, pages 1201-1210.
Read now
Olga Pernía, Cristobal Belda-Iniesta, Veronica Pulido, María Cortes-Sempere, Carlos Rodriguez, Olga Vera, Javier Soto, Julia Jiménez, Alvaro Taus, Federico Rojo, Edurne Arriola, Ana Rovira, Joan Albanell, M Teresa Macías, Javier de Castro, Rosario Perona & Inmaculada Ibañez de Caceres. (2014) Methylation status of IGFBP-3 as a useful clinical tool for deciding on a concomitant radiotherapy. Epigenetics 9:11, pages 1446-1453.
Read now

Articles from other publishers (41)

Kotaro Takeda, Sheldon Bastacky, Rajiv Dhir, Maedeh Mohebnasab & Gabriela M. Quiroga-Garza. (2024) Morphological characteristics of SETD2-mutated locally advanced clear cell renal cell carcinoma: Comparison with BAP1-mutated clear cell renal cell carcinoma. Annals of Diagnostic Pathology 68, pages 152223.
Crossref
Ziwei Gui, Juan Du, Nan Wu, Ningning Shen, Zhiqing Yang, Huijun Yang, Xuzhi Wang, Na Zhao, Zixin Zeng, Rong Wei, Wenxia Ma & Chen Wang. (2023) Immune regulation and prognosis indicating ability of a newly constructed multi-genes containing signature in clear cell renal cell carcinoma. BMC Cancer 23:1.
Crossref
Louis Y. El Khoury, Xiaoyu Pan, Ryan A. Hlady, Ryan T. Wagner, Shafiq Shaikh, Liguo Wang, Mitchell R. Humphreys, Erik P. Castle, Melissa L. Stanton, Thai H. Ho & Keith D. Robertson. (2023) Extensive intratumor regional epigenetic heterogeneity in clear cell renal cell carcinoma targets kidney enhancers and is associated with poor outcome. Clinical Epigenetics 15:1.
Crossref
Xiaoqin Zhang, Ziyue Wang, Zixin Zeng, Ningning Shen, Bin Wang, Yaping Zhang, Honghong Shen, Wei Lu, Rong Wei, Wenxia Ma & Chen Wang. (2021) Bioinformatic analysis identifying FGF1 gene as a new prognostic indicator in clear cell Renal Cell Carcinoma. Cancer Cell International 21:1.
Crossref
Andrea Panunzio, Alessandro Tafuri, Alessandro Princiotta, Ilaria Gentile, Giovanni Mazzucato, Nicolò Trabacchin, Alessandro Antonelli & Maria Angela Cerruto. (2021) Omics in urology: An overview on concepts, current status and future perspectives. Urologia Journal 88:4, pages 270-279.
Crossref
Giuseppe Francesco Racaniello, Valentino Laquintana, Juliette Vergnaud, Angela Lopedota, Annalisa Cutrignelli, Antonio Lopalco, Francesco Leonetti, Massimo Franco, Mauro Fiume, Paola Pontrelli, Loreto Gesualdo, Elias Fattal & Nunzio Denora. (2021) Development of purified glycogen derivatives as siRNA nanovectors. International Journal of Pharmaceutics 608, pages 121128.
Crossref
Xin-da Song, Yi-nong Tian, Hao Li, Bin Liu, Ai-li Zhang & Yang Hong. (2020) Research progress on advanced renal cell carcinoma. Journal of International Medical Research 48:6, pages 030006052092426.
Crossref
Evangelia Pavlidou & Vasileios Balis. (2020) Diagnostic significance and prognostic role of the ARID1A gene in cancer outcomes (Review). World Academy of Sciences Journal.
Crossref
Valeria Maffeis, Rocco Cappellesso, Lorenzo Nicolè, Vincenza Guzzardo, Chiara Menin, Lisa Elefanti, Francesca Schiavi, Maria Guido & Ambrogio Fassina. (2019) Loss of BAP1 in Pheochromocytomas and Paragangliomas Seems Unrelated to Genetic Mutations. Endocrine Pathology 30:4, pages 276-284.
Crossref
Christophe Blanquart, Camille Linot, Pierre-François Cartron, Daniela Tomaselli, Antonello Mai & Philippe Bertrand. (2019) Epigenetic Metalloenzymes. Current Medicinal Chemistry 26:15, pages 2748-2785.
Crossref
Svenja Bihr, Riuko Ohashi, Ariane L. Moore, Jan H. Rüschoff, Christian Beisel, Thomas Hermanns, Axel Mischo, Claudia Corrò, Jörg Beyer, Niko Beerenwinkel, Holger Moch & Peter Schraml. (2019) Expression and Mutation Patterns of PBRM1, BAP1 and SETD2 Mirror Specific Evolutionary Subtypes in Clear Cell Renal Cell Carcinoma. Neoplasia 21:2, pages 247-256.
Crossref
Takashi Hirosawa, Masaharu Ishida, Kentaro Ishii, Keigo Kanehara, Katsuyoshi Kudo, Shinobu Ohnuma, Takashi Kamei, Fuyuhiko Motoi, Takeshi Naitoh, Florin M. Selaru & Michiaki Unno. (2018) Loss of BAP1 expression is associated with genetic mutation and can predict outcomes in gallbladder cancer. PLOS ONE 13:11, pages e0206643.
Crossref
Serena Patrone, Irena Maric, Mariangela Rutigliani, Francesco Lanza, Matteo Puntoni, Barbara Banelli, Silvia Rancati, Giovanna Angelini, Adriana Amaro, Paolo Ligorio, Carlotta Defferrari, Mauro Castagnetta, Roberto Bandelloni, Carlo Mosci, Andrea DeCensi, Massimo Romani, Urlich Pfeffer, Silvia Viaggi & Domenico A. Coviello. (2018) Prognostic value of chromosomal imbalances, gene mutations, and BAP1 expression in uveal melanoma. Genes, Chromosomes and Cancer 57:8, pages 387-400.
Crossref
Ting Luo, Xiaoyi Chen, Shufei Zeng, Baozhang Guan, Bo Hu, Yu Meng, Fanna Liu, Taksui Wong, Yongpin Lu, Chen Yun, Berthold Hocher & Lianghong Yin. (2018) Bioinformatic identification of key genes and analysis of prognostic values in clear cell renal cell carcinoma. Oncology Letters.
Crossref
R. Mager, S. Frees & A. Haferkamp. (2018) „Watchful waiting“ und aktive Überwachung kleiner NierentumorenWatchful waiting and active surveillance of small renal masses. Der Urologe 57:3, pages 295-299.
Crossref
Sarah Hopson & Martin J. Thompson. (2017) BAF180: Its Roles in DNA Repair and Consequences in Cancer. ACS Chemical Biology 12:10, pages 2482-2490.
Crossref
Ganesh M Shankar & Sandro Santagata. (2017) BAP1 mutations in high-grade meningioma: implications for patient care. Neuro-Oncology 19:11, pages 1447-1456.
Crossref
Qing-Lan Li, Pin-Ji Lei, Quan-Yi Zhao, Lianyun Li, Gang Wei & Min Wu. (2017) Epigenomic analysis in a cell-based model reveals the roles of H3K9me3 in breast cancer transformation. Epigenomics 9:8, pages 1077-1092.
Crossref
Katarzyna Kluzek, Malgorzata I. Srebniak, Weronika Majer, Agnieszka Ida, Tomasz Milecki, Kinga Huminska, Robert M. van der Helm, Adrian Silesian, Tomasz M. Wrzesinski, Jacek Wojciechowicz, Berna H. Beverloo, Zbigniew Kwias, Hans A.R. Bluyssen & Joanna Wesoly. (2017) Genetic characterization of Polish ccRCC patients: somatic mutation analysis of PBRM1 , BAP1 and KDMC5 , genomic SNP array analysis in tumor biopsy and preliminary results of chromosome aberrations analysis in plasma cell free DNA . Oncotarget 8:17, pages 28558-28574.
Crossref
Qiu-Yuan Xia, Xue-Mei Zhan, Xiang-Shan Fan, Sheng-Bing Ye, Shan-Shan Shi, Rui Li, Xue Wei, Xuan Wang, Heng-Hui Ma, Zhen-Feng Lu, Xiao-Jun Zhou & Qiu Rao. (2017) BRM/SMARCA2-negative clear cell renal cell carcinoma is associated with a high percentage of BRM somatic mutations, deletions and promoter methylation . Histopathology 70:5, pages 711-721.
Crossref
Lei Liu, Renbo Guo, Xiang Zhang, Yiran Liang, Feng Kong, Jue Wang & Zhonghua Xu. (2017) Loss of SETD2, but not H3K36me3, correlates with aggressive clinicopathological features of clear cell renal cell carcinoma patients. BioScience Trends 11:2, pages 214-220.
Crossref
Mark R. Morris & Farida Latif. (2016) The epigenetic landscape of renal cancer. Nature Reviews Nephrology 13:1, pages 47-60.
Crossref
Quan-Yi Zhao, Pin-Ji Lei, Xiaoran Zhang, Jun-Yi Zheng, Hui-Yi Wang, Jiao Zhao, Yi-Ming Li, Mei Ye, Lianyun Li, Gang Wei & Min Wu. (2016) Global histone modification profiling reveals the epigenomic dynamics during malignant transformation in a four-stage breast cancer model. Clinical Epigenetics 8:1.
Crossref
Klaudia K. Brodaczewska, Cezary Szczylik, Michal Fiedorowicz, Camillo Porta & Anna M. Czarnecka. (2016) Choosing the right cell line for renal cell cancer research. Molecular Cancer 15:1.
Crossref
Caroline Razafinjatovo, Svenja Bihr, Axel Mischo, Ursula Vogl, Manuela Schmidinger, Holger Moch & Peter Schraml. (2016) Characterization of VHL missense mutations in sporadic clear cell renal cell carcinoma: hotspots, affected binding domains, functional impact on pVHL and therapeutic relevance. BMC Cancer 16:1.
Crossref
Courtney Hodges, Jacob G. Kirkland & Gerald R. Crabtree. (2016) The Many Roles of BAF (mSWI/SNF) and PBAF Complexes in Cancer. Cold Spring Harbor Perspectives in Medicine 6:8, pages a026930.
Crossref
YOSHIKAZU TOGO, YOSHIE YOSHIKAWA, TORU SUZUKI, YOSHIRO NAKANO, AKIHIRO KANEMATSU, MASATAKA ZOZUMI, MICHIO NOJIMA, SEIICHI HIROTA, SHINGO YAMAMOTO & TOMOKO HASHIMOTO-TAMAOKI. (2016) Genomic profiling of the genes on chromosome 3p in sporadic clear cell renal cell carcinoma. International Journal of Oncology 48:4, pages 1571-1580.
Crossref
Sung Yeon Park, Jong-Wan Park & Yang-Sook Chun. (2016) Jumonji histone demethylases as emerging therapeutic targets. Pharmacological Research 105, pages 146-151.
Crossref
Umberto Capitanio & Francesco Montorsi. (2016) Renal cancer. The Lancet 387:10021, pages 894-906.
Crossref
J.N. Nichol, D. Dupéré-Richer, T. Ezponda, J.D. Licht & W.H. MillerJr.Jr.. 2016. 59 95 .
T L Pritchett, H L Bader, J Henderson & T Hsu. (2014) Conditional inactivation of the mouse von Hippel–Lindau tumor suppressor gene results in wide-spread hyperplastic, inflammatory and fibrotic lesions in the kidney. Oncogene 34:20, pages 2631-2639.
Crossref
Ricardo E. Vilain, Stanley W. McCarthy, John F. Thompson & Richard A. Scolyer. (2015) BAP1-inactivated Spitzoid Naevi. American Journal of Surgical Pathology 39:5, pages 722.
Crossref
Masaki Nasu, Mitsuru Emi, Sandra Pastorino, Mika Tanji, Amy Powers, Hugh Luk, Francine Baumann, Yu-an Zhang, Adi Gazdar, Shreya Kanodia, Maarit Tiirikainen, Erin Flores, Giovanni Gaudino, Michael J. Becich, Harvey I. Pass, Haining Yang & Michele Carbone. (2015) High Incidence of Somatic BAP1 Alterations in Sporadic Malignant Mesothelioma. Journal of Thoracic Oncology 10:4, pages 565-576.
Crossref
Wei Xiang, Jun He, Chao Huang, Lejun Chen, Dan Tao, Xinchao Wu, Miao Wang, Gang Luo, Xingyuan Xiao, Fuqing Zeng & Guosong Jiang. (2015) miR-106b-5p targets tumor suppressor gene SETD2 to inactive its function in clear cell renal cell carcinoma. Oncotarget 6:6, pages 4066-4079.
Crossref
Ben Xu, Lian Zhang, Cheng Luo, Yan Qi, Yun Cui, Jian-Ming Ying, Qian Zhang & Jie Jin. (2015) Hypermethylation of the 16q23.1 Tumor Suppressor Gene ADAMTS18 in Clear Cell Renal Cell Carcinoma. International Journal of Molecular Sciences 16:1, pages 1051-1065.
Crossref
Ruhee Dere & Thai H. Ho. 2015. Renal Cell Carcinoma. Renal Cell Carcinoma 153 165 .
Stephen M. Keefe, W. Kimryn Rathmell & Katherine L. Nathanson. 2015. Renal Cell Carcinoma. Renal Cell Carcinoma 39 56 .
Qiu-yuan Xia, Qiu Rao, Liang Cheng, Qin Shen, Shan-shan Shi, Li Li, Biao Liu, Jin Zhang, Yan-fen Wang, Qun-li Shi, Jian-dong Wang, Heng-hui Ma, Zhen-feng Lu, Bo Yu, Ru-song Zhang & Xiao-jun Zhou. (2014) Loss of BRM expression is a frequently observed event in poorly differentiated clear cell renal cell carcinoma. Histopathology 64:6, pages 847-862.
Crossref
Xiaofan Zhu, Fuhong He, Huimin Zeng, Shaoping Ling, Aili Chen, Yaqin Wang, Xiaomei Yan, Wei Wei, Yakun Pang, Hui Cheng, Chunlan Hua, Yue Zhang, Xuejing Yang, Xin Lu, Lihua Cao, Lingtong Hao, Lili Dong, Wei Zou, Jun Wu, Xia Li, Si Zheng, Jin Yan, Jing Zhou, Lixia Zhang, Shuangli Mi, Xiaojuan Wang, Li Zhang, Yao Zou, Yumei Chen, Zhe Geng, Jianmin Wang, Jianfeng Zhou, Xin Liu, Jianxiang Wang, Weiping Yuan, Gang Huang, Tao Cheng & Qian-fei Wang. (2014) Identification of functional cooperative mutations of SETD2 in human acute leukemia. Nature Genetics 46:3, pages 287-293.
Crossref
Kimberly Mayes, Zhijun Qiu, Aiman Alhazmi & Joseph W. Landry. 2014. 183 233 .
Wei Li, Wei Zhu, Jianping Che, Wei Sun, Min Liu, Bo Peng & Junhua Zheng. (2013) Microarray Profiling of Human Renal Cell Carcinoma: Identification for Potential Biomarkers and Critical Pathways. Kidney and Blood Pressure Research 37:4-5, pages 506-513.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.